New glasses aim to slow nearsightedness in children
NCT ID NCT07497672
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two new types of multifocal glasses designed to manage myopia (nearsightedness) in children aged 8 to 15. Twenty kids who already wear myopia-control glasses will try each new design for a short time to see how well they see and how comfortable they feel. The goal is to find better options for slowing down worsening nearsightedness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multifocal spectacle lenses
- What this could lead to
- If successful, these glasses could offer a new option for slowing myopia progression in children.
- What could go wrong
- This is a very small, short-term study (20 participants) focused on immediate vision and comfort, not long-term myopia control. Results may not predict real-world effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 to 15 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. 8 - 15 years of age, inclusive. 2. Ability of the child to assent, and for one parent to provide permission to participate. 3. Had an eye examination within the past year. 4. Distance visual acuity of 20/25 (logMAR +0.10) or better in each eye with best corrected with sph/cyl subjective refraction. 5. Habitual glasses wearer of either MiYOSMART or Stellest for at least 2 months. (Can also be a contact lens wearer but needs to wear either MiYOSMART or Stellest spectacles for a minimum of 6 hours on a typical day.) 6. No history of binocular function anomaly (e.g., no history of strabismus), and no apparent strabismus. 7. Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data, as determined by the investigator). Exclusion Criteria: 1. Current report of active ocular inflammation or infection. 2. Astigmatism \> 1.00 D in either eye 3. History of previous eye surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Myopia: refractive error are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.